Laboratorios Farmaceúticos Rovi (Spain)

Recent papers from Laboratorios Farmaceúticos Rovi (Spain)

1. Impact of Anti-HER2 Therapies on Potentially Avoidable Deaths from Stage II and III HER2-Positive Breast Cancer in the Brazilian Public Healthcare SystemThe Breast · 2026
2. Effects of minerals and xylitol solution on human nasal epithelium: Water channels upregulation and potential anti-inflammatory propertiesBrazilian Journal of Otorhinolaryngology · 2026
3. Comparative analysis of Pharmaceutical Care practice in rural and urban community pharmacies in Valencia, Spain: a quasi-experimental studyBMC Health Services Research · 2026
4. Safety and efficacy of puxitatug samrotecan (Puxi-Sam, AZD8205) in patients with biliary tract cancer (BTC): A first-in-human phase 1/2a study (BLUESTAR).Journal of Clinical Oncology · 2026
5. D26-14 The Brazilian Inhaler Paradox: Environmental Success in Maintenance Therapy (LABA/ICS) Undermined by a Worsening Saba Over-reliance Compared to the USAmerican Journal of Respiratory and Critical Care Medicine · 2026
6. C38-03 Gaps in Asthma Perception and Management Recommendations Between Specialists and Non-Specialists in Brazil: Findings From the Prasma SurveyAmerican Journal of Respiratory and Critical Care Medicine · 2026
7. [Translated article] Surface disinfectants used in healthcare environmentsFarmacia Hospitalaria · 2026
8. Risperidone-ISM® effectiveness and tolerability in acute schizophrenia patients hospitalised due to a relapse: results from an international, prospective, non-interventional evaluation (RESHAPE study).2026
9. Comparison of dopamine D2 receptor occupancy profiles between risperidone ISM versus oral risperidone and monthly paliperidone palmitate based on population pharmacokinetic modelling and simulationsExpert Review of Clinical Pharmacology · 2025
10. Comparison of dopamine D2 receptor occupancy profiles between risperidone ism versus oral risperidone and monthly paliperidone palmitate based on population pharmacokinetic modelling and simulationsExpert Review of Clinical Pharmacology · 2025
11. Screening for Undiagnosed Atrial Fibrillation in Community Pharmacies using mobile electrocardiogram technology: A Quasi-Experimental Cross- Sectional Study (PREVENIM ICTUS)2025
12. Attitudes of Italian psychiatrists towards the use of Long-Acting Injectable antipsychotics in the management of schizophrenia relapse: insights from the ALIA studySchizophrenia Research · 2025
13. No sex-related differences in PANSS score reductions in adult patients with acutely exacerbated schizophrenia treated with Risperidone ISMEuropean Psychiatry · 2025
14. No sex-related differences in CGI-S score reductions in adult patients with acutely exacerbated schizophrenia treated with Risperidone ISMEuropean Psychiatry · 2025
15. Sex-related differences in long-term tolerability of Risperidone ISM treatment in adult patients with schizophreniaEuropean Psychiatry · 2025
16. Equity in Respiratory Health: Actionable Recommendations for SpainOpen Respiratory Archives · 2025
17. [Exploring the Connection Between Pain, Age, Sex, Quality of Life, Functional Capacity, And Sleep: An Analysis in Community Pharmacy].2025
18. Frailty Prevalence and Characterization Among Kidney Transplant Candidates in Spain: A Multicenter StudyTransplant International · 2025
19. Development and evaluation of a model characterizing the release characteristics of a new letrozole long-acting injectable formulationEuropean Journal of Pharmaceutical Sciences · 2025
20. Retreatment with Brentuximab Vedotin in Patients with Relapsed/Refractory CD30+ Malignancies: A Retrospective Medical Chart Review Study in Spain-The BELIEVE StudyCancers · 2025